[Biological response modifiers and their use in urology: our experience].
Fontana
G
G
Div. Urologica usl 8, Ospedale Maggiore S. Giovanni Battista Torino.
Bozzo
R
R
Sesia
G
G
Cavallo
G P
GP
Forni
G
G
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002278:Carcinoma in Situ / Q000628:therapy*; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011292:Premedication; D013949:Thymus Extracts / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*; D014552:Urinary Tract Infections / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D013949:Thymus Extracts; C031407:thymostimulin; D007371:Interferon-gamma
I farmaci modificatori della risposta biologica ed il loro impiego in urologia: nostra esperienza.